Interestingly, in mutant as well as non-mutant gliomas, RIPK3 expression can additionally stratify the risk of patients: high RIPK3 expression is correlated with a worse prognosis contrasting to most other entities [8]. The gene discussed is RIPK3; the disease is glioma.